CIK 0000897448 · Accelerated filer
AMARIN CORP PLCUK
Sign in to watch- Ticker
- AMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 353 1 6699 020
- Business address
- SPACES SOUTH DOCKLANDS, BLOCK C, 77 SIR JOHN ROGERSON'S QUAY, DUBLIN 2, Ireland
- Former names
- AMARIN CORP PLC\UK, AMARIN PHARMACEUTICALS PLC, ETHICAL HOLDINGS PLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-01-27 | Ketchum Steven B Chief Scientific Officer | Option exercise | +23,436 | $1.40 | $33K | 676,823 |
| 2021-01-27 | Ketchum Steven B Chief Scientific Officer | Option exercise | +47,605 | $2.95 | $140K | 724,428 |
| 2021-01-27 | Ketchum Steven B Chief Scientific Officer | Option exercise | +85,313 | $3.80 | $324K | 809,741 |
| 2021-01-27 | Ketchum Steven B Chief Scientific Officer | Sale | −278,237 | $8.01 | $2.2M | 531,504 |
| 2021-01-27 | Ketchum Steven B Chief Scientific Officer | Sale | −143,392 | $8.01 | $1.1M | 388,112 |
| 2021-01-27 | Ketchum Steven B Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −25,389 | 0 | ||
| 2021-01-27 | Ketchum Steven B Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −8,332 | 0 | ||
| 2021-01-27 | Ketchum Steven B Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −5,797 | 16,703 | ||
| 2021-01-27 | Ketchum Steven B Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −52,938 | 0 | ||
| 2021-01-27 | Ketchum Steven B Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −29,427 | 164,573 | ||
| 2021-01-27 | Ketchum Steven B Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −23,436 | 0 | ||
| 2021-01-27 | Ketchum Steven B Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −47,605 | 11,082 | ||
| 2021-01-27 | Ketchum Steven B Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −85,313 | 31,687 | ||
| 2021-01-04 | Berg Aaron CHIEF COMMERCIAL OFFICER | Grant or award · Stock Option (Right to Buy) | +193,500 | 193,500 | ||
| 2021-01-04 | Berg Aaron CHIEF COMMERCIAL OFFICER | Grant or award · Restricted Stock Units | +143,300 | 143,300 | ||
| 2021-01-04 | Kalb Michael Wayne SVP and CFO | Grant or award · Stock Option (Right to Buy) | +193,500 | 193,500 | ||
| 2021-01-04 | Kalb Michael Wayne SVP and CFO | Grant or award · Restricted Stock Units | +143,300 | 143,300 | ||
| 2021-01-04 | Ketchum Steven B Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +193,500 | 193,500 | ||
| 2021-01-04 | Ketchum Steven B Chief Scientific Officer | Grant or award · Restricted Stock Units | +143,300 | 143,300 | ||
| 2021-01-04 | Kennedy Joseph T General Counsel | Grant or award · Stock Option (Right to Buy) | +193,500 | 193,500 |
Page 40 of 67 · 1,339 trades